A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

Clinical trial NCT06799533 · TERMINATED

Trial details

NCT number: NCT06799533
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma Melanoma Metastatic Melanoma Solid Tumors

Start date: 2025-05-01
Primary completion: 2026-02-23
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.